 |
 |
 |
 |
 |
 |
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
||||||
 |
Administration |
Technology and Achievements Scientists at the Sbarro Institute for Cancer Research and Molecular Medicine have completed research on new technologies designed to diagnose lung, ovarian, endometrial, breast and brain tumors as well as lymphomas. Their work with gene therapy has also led to new strategies to treat tumors of the lung and brain. Since 1995, the Institute has organized and co-sponsored scientific meetings around the world. Under the auspices of SHRO, international cancer experts have gathered in the United States, Italy and Argentina, to promote the exchange of ideas and to lead to new collaborative efforts in the fight against disease. |
 SHRO Researchers Andrew Puca and Andrew Gambone work on the next SHRO discovery. |
|||
Scientific Journals Anticancer Research
|
At present, SHRO is the exclusive licensee of nine worldwide patents for novel diagnostic and therapeutic applications in the treatment of cancer and cardiovascular disease. Some of these technologies will require approval from the Food and Drug Administration (FDA) before use in humans. 
The research of Sbarro scientists and other SHRO funded work have been published in over 200 international scientific journals. |
||||
 |
 |
||||||
 |
|||||||
 |
|||||||
© Copyright 2003, Sbarro Health Research Organization,All rights reserved. |